Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence.

Rabin RA, Dermody SS, George TP.

Drug Alcohol Depend. 2018 Apr 1;185:181-188. doi: 10.1016/j.drugalcdep.2017.12.017. Epub 2018 Feb 12.

PMID:
29459327
2.

Commentary on Stewart et al. (2017): Stimulants and marijuana-the potential value in studying substance co-use.

Rabin RA, Moeller SJ.

Addiction. 2017 Sep;112(9):1578-1579. doi: 10.1111/add.13871. No abstract available.

PMID:
28778123
3.

A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.

Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP.

Schizophr Res. 2018 Apr;194:47-54. doi: 10.1016/j.schres.2017.05.006. Epub 2017 May 12.

PMID:
28506704
4.

Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.

Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP.

Neuropsychopharmacology. 2017 Oct;42(11):2259-2271. doi: 10.1038/npp.2017.85. Epub 2017 Apr 26.

5.

Effects of varenicline on cognitive function in non-smokers with schizophrenia.

Kozak K, Dermody SS, Rabin RA, Zack M, Barr MS, Tyndale RF, George TP.

Schizophr Res. 2018 Jul;197:562-563. doi: 10.1016/j.schres.2017.03.023. Epub 2017 Mar 11. No abstract available.

PMID:
28291692
6.

Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.

Rabin RA, Kozak K, Zakzanis KK, Remington G, George TP.

Schizophr Res. 2018 Apr;194:55-61. doi: 10.1016/j.schres.2017.03.010. Epub 2017 Mar 9.

PMID:
28285022
7.

Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls.

Goodman MS, Bridgman AC, Rabin RA, Blumberger DM, Rajji TK, Daskalakis ZJ, George TP, Barr MS.

Brain Stimul. 2017 Mar - Apr;10(2):275-282. doi: 10.1016/j.brs.2016.11.004. Epub 2016 Nov 14.

PMID:
27964871
8.

Cannabis and psychosis: understanding the smoke signals.

Rabin RA, George TP.

Lancet Psychiatry. 2016 Oct;3(10):909-910. doi: 10.1016/S2215-0366(16)30230-9. Epub 2016 Aug 23. No abstract available.

9.

Understanding the Link Between Cannabinoids and Psychosis.

Rabin RA, George TP.

Clin Pharmacol Ther. 2017 Feb;101(2):197-199. doi: 10.1002/cpt.421. Epub 2016 Aug 13.

PMID:
27367612
10.

Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.

Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW Jr, Lerman C, Tyndale RF, George TP.

Am J Addict. 2016 Jun;25(4):291-6. doi: 10.1111/ajad.12382. Epub 2016 May 17.

PMID:
27187893
11.

Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers.

Morozova M, Rabin RA, George TP.

Am J Addict. 2015 Dec;24(8):687-94. doi: 10.1111/ajad.12277. Epub 2015 Sep 10. Review.

PMID:
26354720
12.

A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use.

Rabin RA, George TP.

Am J Addict. 2015 Mar;24(2):105-16. doi: 10.1111/ajad.12186. Epub 2015 Feb 6. Review.

PMID:
25662704
13.

Relationship between tobacco and cannabis use status in outpatients with schizophrenia.

Rabin RA, Giddens JL, George TP.

Am J Addict. 2014 Mar-Apr;23(2):170-5. doi: 10.1111/j.1521-0391.2013.12084.x. Epub 2013 Aug 31.

PMID:
25187052
14.

Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.

Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:79-85. doi: 10.1016/j.pnpbp.2013.07.010. Epub 2013 Jul 19. Review.

15.

Varenicline modulates spatial working memory deficits in smokers with schizophrenia.

Wing VC, Wass CE, Bacher I, Rabin RA, George TP.

Schizophr Res. 2013 Sep;149(1-3):190-1. doi: 10.1016/j.schres.2013.06.032. Epub 2013 Jul 11. No abstract available.

PMID:
23849883
16.

Effects of cannabis use status on cognitive function, in males with schizophrenia.

Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP.

Psychiatry Res. 2013 Apr 30;206(2-3):158-65. doi: 10.1016/j.psychres.2012.11.019. Epub 2012 Dec 13.

PMID:
23246245
17.

Correlations between executive function, decision-making and impulsivity are disrupted in schizophrenia versus controls.

Wing VC, Rabin RA, Wass CE, George TP.

Psychiatry Res. 2013 Jan 30;205(1-2):168-71. doi: 10.1016/j.psychres.2012.08.022. Epub 2012 Sep 25.

PMID:
23017650
18.

Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls.

Wing VC, Moss TG, Rabin RA, George TP.

Addict Behav. 2012 Jan;37(1):67-72. doi: 10.1016/j.addbeh.2011.08.012. Epub 2011 Sep 8.

PMID:
21963152
19.

A comparison of imputation procedures and statistical tests for the analysis of two-dimensional electrophoresis data.

Miecznikowski JC, Damodaran S, Sellers KF, Coling DE, Salvi R, Rabin RA.

Proteome Sci. 2011 Mar 29;9:14. doi: 10.1186/1477-5956-9-14. No abstract available.

20.

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.

Rabin RA, Zakzanis KK, George TP.

Schizophr Res. 2011 May;128(1-3):111-6. doi: 10.1016/j.schres.2011.02.017. Epub 2011 Mar 21. Review.

PMID:
21420282
21.

A comparison of imputation procedures and statistical tests for the analysis of two-dimensional electrophoresis data.

Miecznikowski JC, Damodaran S, Sellers KF, Rabin RA.

Proteome Sci. 2010 Dec 15;8:66. doi: 10.1186/1477-5956-8-66.

22.

Gender differences in ethanol-induced behavioral sensitivity in zebrafish.

Dlugos CA, Brown SJ, Rabin RA.

Alcohol. 2011 Feb;45(1):11-8. doi: 10.1016/j.alcohol.2010.08.018. Epub 2010 Sep 29.

PMID:
20880661
23.

Structural and functional effects of developmental exposure to ethanol on the zebrafish heart.

Dlugos CA, Rabin RA.

Alcohol Clin Exp Res. 2010 Jun;34(6):1013-21. doi: 10.1111/j.1530-0277.2010.01176.x. Epub 2010 Apr 5.

PMID:
20374213
24.

Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.

Rabin RA, Sacco KA, George TP.

Schizophr Res. 2009 Oct;114(1-3):91-7. doi: 10.1016/j.schres.2009.07.006. Epub 2009 Aug 4.

25.

Evaluating peptide mass fingerprinting-based protein identification.

Damodaran S, Wood TD, Nagarajan P, Rabin RA.

Genomics Proteomics Bioinformatics. 2007 Dec;5(3-4):152-7. doi: 10.1016/S1672-0229(08)60002-9.

26.

d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.

Reissig CJ, Rabin RA, Winter JC, Dlugos CA.

Eur J Pharmacol. 2008 Mar 31;583(1):40-7. doi: 10.1016/j.ejphar.2007.12.031. Epub 2008 Jan 7.

PMID:
18262520
27.

Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons.

Bucelli RC, Gonsiorek EA, Kim WY, Bruun D, Rabin RA, Higgins D, Lein PJ.

J Pharmacol Exp Ther. 2008 Mar;324(3):1172-80. Epub 2007 Dec 13.

PMID:
18079356
28.

The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC.

Pharmacol Biochem Behav. 2008 Jan;88(3):312-7. Epub 2007 Sep 19.

29.

Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice.

Krall CM, Richards JB, Rabin RA, Winter JC.

Pharmacol Biochem Behav. 2008 Jan;88(3):349-57. Epub 2007 Sep 14.

30.

Mechanism of ethanol enhancement of apoptosis and caspase activation in serum-deprived PC12 cells.

Krzyzanski W, Oberdoester J, Rabin RA.

Life Sci. 2007 Aug 9;81(9):756-64. Epub 2007 Jul 26.

PMID:
17706724
31.

Psilocybin-induced stimulus control in the rat.

Winter JC, Rice KC, Amorosi DJ, Rabin RA.

Pharmacol Biochem Behav. 2007 Oct;87(4):472-80. Epub 2007 Jun 22.

32.

Minimizing variability in two-dimensional electrophoresis gel image analysis.

Damodaran S, Rabin RA.

OMICS. 2007 Summer;11(2):225-30.

PMID:
17594240
33.

Ocular deficits associated with alcohol exposure during zebrafish development.

Dlugos CA, Rabin RA.

J Comp Neurol. 2007 Jun 1;502(4):497-506.

PMID:
17394139
34.

Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system.

Damodaran S, Dlugos CA, Wood TD, Rabin RA.

Eur J Pharmacol. 2006 Oct 10;547(1-3):75-82. Epub 2006 Aug 15.

PMID:
16978605
35.

Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.

Pharmacol Biochem Behav. 2006 Jan;83(1):122-9. Epub 2006 Feb 3.

PMID:
16460788
36.

The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Reissig CJ, Eckler JR, Rabin RA, Winter JC.

Psychopharmacology (Berl). 2005 Oct;182(2):197-204. Epub 2005 Oct 19.

37.

The stimulus properties of LSD in C57BL/6 mice.

Winter JC, Kieres AK, Zimmerman MD, Reissig CJ, Eckler JR, Ullrich T, Rice KC, Rabin RA, Richards JB.

Pharmacol Biochem Behav. 2005 Aug;81(4):830-7.

38.

Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.

Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.

Psychopharmacology (Berl). 2005 Sep;181(3):496-503. Epub 2005 Oct 12.

39.

Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.

Doat-Meyerhoefer MM, Hard R, Winter JC, Rabin RA.

Pharmacol Biochem Behav. 2005 Aug;81(4):750-7.

40.

Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Winter JC, Eckler JR, Rice KC, Rabin RA.

Pharmacol Biochem Behav. 2005 Jul;81(3):694-700.

41.

A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.

Eckler JR, Reissig CJ, Rabin RA, Winter JC.

Pharmacol Biochem Behav. 2004 Sep;79(1):25-30.

PMID:
15388280
42.

Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.

Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA.

Brain Res. 2004 Oct 8;1023(1):134-40.

PMID:
15364028
43.

Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.

Regina MJ, Bucelli RC, Winter JC, Rabin RA.

Brain Res. 2004 Apr 2;1003(1-2):168-75.

PMID:
15019576
44.
45.

Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.

Winter JC, Eckler JR, Rabin RA.

Psychopharmacology (Berl). 2004 Mar;172(2):233-40. Epub 2003 Nov 4.

PMID:
14598016
46.

Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.

Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC.

Pharmacol Biochem Behav. 2003 Jul;75(4):845-52.

PMID:
12957227
47.

Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.

Eckler JR, Rabin RA, Winter JC.

Pharmacol Biochem Behav. 2003 May;75(2):405-10.

PMID:
12873632
48.

Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.

Doat MM, Rabin RA, Winter JC.

Pharmacol Biochem Behav. 2003 Feb;74(3):713-21.

PMID:
12543238
49.

Adult blood lead epidemiology and surveillance--United States, 1998-2001.

Roscoe RJ, Ball W, Curran JJ, DeLaurier C, Falken MC, Fitchett R, Fleissner ML, Fletcher AE, Garman SJ, Gergely RM, Gerwel BT, Gostin JE, Keyvan-Larijani E, Leiker RD, Lofgren JP, Nelson DR, Payne SF, Rabin RA, Salzman DL, Schaller KE, Sims AS, Smith JD, Socie EM, Stoeckel M, Stone RR, Whittaker SG.

MMWR Surveill Summ. 2002 Dec 13;51(11):1-10.

50.

Ethanol effects on three strains of zebrafish: model system for genetic investigations.

Dlugos CA, Rabin RA.

Pharmacol Biochem Behav. 2003 Jan;74(2):471-80.

PMID:
12479969

Supplemental Content

Loading ...
Support Center